Profile for Canada Patent: 3204396
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Canada Patent: 3204396
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Apr 11, 2036 | Axsome | SYMBRAVO | meloxicam; rizatriptan benzoate |
| ⤷ Start Trial | Apr 11, 2036 | Axsome | SYMBRAVO | meloxicam; rizatriptan benzoate |
| ⤷ Start Trial | Apr 11, 2036 | Axsome | SYMBRAVO | meloxicam; rizatriptan benzoate |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
